---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-019987"
form_type: "8-K"
ticker: "ENSC"
cik: "0001716947"
company_name: "Ensysce Biosciences, Inc."
filed_at: "2023-06-02T23:59:59+00:00"
generated_at: "2026-06-14T08:23:18.461058+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Ensysce completes $7M offering, believes it meets Nasdaq equity requirement

## Summary
- Raised ~$7M gross via public offering of common stock and warrants on May 12, 2023.
- Previously notified of non-compliance with Nasdaq's $2.5M stockholders' equity minimum.
- Hearings Panel granted extension to June 12, 2023; company now believes it satisfies the Rule.
- Awaiting formal Nasdaq confirmation of compliance status.

## SEC filing metadata
- accession: 0001493152-23-019987
- form_type: 8-K
- ticker: ENSC
- cik: 0001716947
- company_name: Ensysce Biosciences, Inc.
- filed_at: 2023-06-02T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716947/000149315223019987/0001493152-23-019987-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716947/000149315223019987/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-019987
- JSON: https://secwatch.observer/filing/0001493152-23-019987.json
- Plain text: https://secwatch.observer/filing/0001493152-23-019987.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.